Synonyms: compound C9 [WO2020081879A2] | PTC-857 | PTC857
Compound class:
Synthetic organic
Comment: Utreloxastat (PTC-857) is described as a 15-lipoxygenase inhibitor in its INN record. It was developed for potential to treat α-synucleinopathies, tauopathies, ALS and other brain injuries/insults [1].
|
|
Classification | |
Compound class | Synthetic organic |
IUPAC Name |
2,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione |
International Nonproprietary Names | |
INN number | INN |
11733 | utreloxastat |
Synonyms |
compound C9 [WO2020081879A2] | PTC-857 | PTC857 |
Database Links | |
CAS Registry No. | 1213269-96-5 (source: WHO INN record) |
GtoPdb PubChem SID | 491300042 |
PubChem CID | 46174641 |
Search Google for chemical match using the InChIKey | IJWAQTHZBDBIID-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | IJWAQTHZBDBIID |
Search PubMed clinical trials | utreloxastat |
Search PubMed titles | utreloxastat |
Search PubMed titles/abstracts | utreloxastat |
UniChem Compound Search for chemical match using the InChIKey | IJWAQTHZBDBIID-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | IJWAQTHZBDBIID-UHFFFAOYSA-N |